Subtopic Deep Dive

Fatty Acid Biosynthesis
Research Guide

What is Fatty Acid Biosynthesis?

Fatty acid biosynthesis is the enzymatic process converting acetyl-CoA to palmitate via multi-enzyme complexes in cytosol of animals, plants, and microbes.

Pathways involve acetyl-CoA carboxylase (ACC) for malonyl-CoA production and fatty acid synthase (FAS) type I or II systems. SREBPs regulate genes for complete synthesis program (Horton et al., 2002, 3916 citations). Over 30 genes activated by SREBPs control cholesterol and fatty acid production in liver.

Curated Papers

Key Challenges

Why It Matters

Fatty acid biosynthesis pathways enable engineering microbial strains for biofuel production by altering lipid profiles. In cancer, de novo synthesis supports tumor growth, as shown by upregulated FAS in malignant cells (Röhrig and Schulze, 2016). Therapeutic targeting of ACC and SREBP improves insulin sensitivity in obesity-linked diabetes (Samuel and Shulman, 2012; Guilherme et al., 2008). Dysregulated synthesis contributes to lipotoxicity in non-adipose tissues, protected by triglyceride storage (Listenberger et al., 2003).

Key Research Challenges

SREBP Regulation Complexity

SREBPs activate 30+ genes but face feedback inhibition challenges in vivo. Horton's 2002 study (3916 citations) details liver-specific activation, yet tissue-specific differences persist. Modeling full regulatory networks remains unresolved (Eberlé et al., 2004).

Lipotoxicity Mechanisms

Excess fatty acids induce cell death variably by chain length, countered by triglyceride buffering (Listenberger et al., 2003, 1992 citations). Mechanisms linking synthesis to insulin resistance in muscle unclear (Yu et al., 2002). Quantifying thresholds for protection vs. toxicity needs refinement.

Cancer Metabolic Rewiring

Tumors reprogram fatty acid synthesis for proliferation, but dependencies on de novo vs. uptake debated (Röhrig and Schulze, 2016; Koundouros and Poulogiannis, 2019). Genetic loci from GWAS inform risks but causal variants elusive (Willer et al., 2013, 3226 citations).

Essential Papers

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

Jay D. Horton, Joseph L. Goldstein, Michael S. Brown · 2002 · Journal of Clinical Investigation · 3.9K citations

Lipid homeostasis in vertebrate cells is regulated by a family of membrane-bound transcription factors designated sterol regulatory element-binding proteins (SREBPs).SREBPs directly activate the ex...

Discovery and refinement of loci associated with lipid levels

Cristen J. Willer, Ellen M. Schmidt, Sebanti Sengupta et al. · 2013 · Nature Genetics · 3.2K citations

Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes

Adı́lson Guilherme, Joseph V. Virbasius, Vishwajeet Puri et al. · 2008 · Nature Reviews Molecular Cell Biology · 2.2K citations

Mechanisms for Insulin Resistance: Common Threads and Missing Links

Varman T. Samuel, Gerald I. Shulman · 2012 · Cell · 2.1K citations

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

Laura Listenberger, Xianlin Han, Sarah E. Lewis et al. · 2003 · Proceedings of the National Academy of Sciences · 2.0K citations

Excess lipid accumulation in non-adipose tissues is associated with insulin resistance, pancreatic β-cell apoptosis and heart failure. Here, we demonstrate in cultured cells that the relative toxic...

Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism

Bart Staels, Jean Dallongeville, Johan Auwerx et al. · 1998 · Circulation · 1.8K citations

Abstract —Treatment with fibrates, a widely used class of lipid-modifying agents, results in a substantial decrease in plasma triglycerides and is usually associated with a moderate decrease in LDL...

The multifaceted roles of fatty acid synthesis in cancer

Florian Röhrig, Almut Schulze · 2016 · Nature reviews. Cancer · 1.6K citations

Reading Guide

Foundational Papers

Start with Horton et al. (2002, 3916 citations) for SREBP regulation of synthesis genes, then Listenberger et al. (2003) for lipotoxicity mechanisms, and Willer et al. (2013) for genetic loci.

Recent Advances

Study Röhrig and Schulze (2016) on cancer synthesis roles and Koundouros and Poulogiannis (2019) on metabolic reprogramming.

Core Methods

Core techniques: SREBP ChIP assays (Horton 2002), fatty acid toxicity assays in cell culture (Listenberger 2003), GWAS meta-analysis (Willer 2013), and PI3K inhibition studies (Yu 2002).

How PapersFlow Helps You Research Fatty Acid Biosynthesis

Discover & Search

Research Agent uses searchPapers and citationGraph on 'SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver' (Horton et al., 2002) to map 3916 citing papers, revealing regulation clusters. exaSearch queries 'fatty acid synthase cancer reprogramming' for 250M+ OpenAlex papers, while findSimilarPapers expands to related insulin resistance works like Samuel and Shulman (2012).

Analyze & Verify

Analysis Agent applies readPaperContent to extract SREBP gene targets from Horton et al. (2002), then verifyResponse with CoVe cross-checks claims against Listenberger et al. (2003) for lipotoxicity data. runPythonAnalysis plots citation trends or lipid level GWAS data from Willer et al. (2013) using pandas, with GRADE scoring evidence strength for synthesis-insulin links.

Synthesize & Write

Synthesis Agent detects gaps in cancer fatty acid reprogramming between Röhrig and Schulze (2016) and Koundouros and Poulogiannis (2019), flagging contradictions on FAS dependency. Writing Agent uses latexEditText for pathway diagrams, latexSyncCitations to integrate 10+ refs, and latexCompile for review-ready manuscripts; exportMermaid visualizes SREBP regulatory networks.

Use Cases

"Analyze lipotoxicity data from Listenberger 2003 with stats on fatty acid chain effects"

Research Agent → searchPapers('Listenberger lipotoxicity') → Analysis Agent → readPaperContent + runPythonAnalysis (pandas plot toxicity ratios by chain length) → matplotlib figure of dose-response curves.

"Write LaTeX review on SREBP regulation in fatty acid synthesis"

Synthesis Agent → gap detection (Horton 2002 vs Eberlé 2004) → Writing Agent → latexEditText (add SREBP pathway) → latexSyncCitations (10 refs) → latexCompile → PDF with compiled equations.

"Find code for modeling fatty acid synthase kinetics from papers"

Research Agent → paperExtractUrls (query biosynthesis models) → paperFindGithubRepo → Code Discovery → githubRepoInspect (extract Python sims) → runPythonAnalysis sandbox test.

Automated Workflows

Deep Research workflow scans 50+ papers on SREBP-lipid links via searchPapers → citationGraph → structured report with GRADE scores on regulation evidence. DeepScan applies 7-step CoVe to verify GWAS lipid loci (Willer et al., 2013) against functional studies. Theorizer generates hypotheses on FAS inhibitors from cancer papers (Röhrig 2016, Koundouros 2019).

Try Doxa for Fatty Acid Biosynthesis Research

Frequently Asked Questions

What defines fatty acid biosynthesis?

It is the de novo cytosolic synthesis of palmitate from acetyl-CoA via ACC and FAS enzymes, regulated by SREBPs activating 30+ genes (Horton et al., 2002).

What are key methods in fatty acid biosynthesis research?

Methods include ChIP-seq for SREBP binding, lipidomics for flux analysis, and CRISPR knockout of ACC/FAS; GWAS identifies loci (Willer et al., 2013).

What are seminal papers?

Horton et al. (2002, 3916 citations) on SREBPs; Listenberger et al. (2003, 1992 citations) on lipotoxicity; Röhrig and Schulze (2016) on cancer roles.